Clinical Study
P-Cresyl Sulfate Is a Valuable Predictor of Clinical Outcomes in Pre-ESRD Patients
Table 1
Baseline characteristics of the study patients.
| | Variables | All () |
| | Age (yr) | | | Male (%) | 50% | | Diabetes mellitus (%) | 31.9% | | Hypertension (%) | 43.1% | | CVD (%) | 15.3% | | SBP (mmHg) | | | DBP (mmHg) | | | CKD stage (%) | | | 3 | 34.8% | | 4 | 32.4% | | 5 | 32.8% | | Albumin (g/dL) | | | Hemoglobin (g/L) | | | Hematocrit (%) | | | BUN (mg/dL) | | | Creatinine (mg/dL) | | | eGFR (mL/min) | | | Calcium (mg/dL) | | | Phosphate (mg/dL) | | | Intact-PTH (pg/mL) | | | P-cresyl sulfate (mg/L) | |
|
|
Values expressed as mean ± SD or percent. CVD: cardiovascular disease; CKD: chronic kidney disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; eGFR: estimated GFR.
|
